Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Chemotherapy”

2,141 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,141 results

Testing effectiveness (Phase 2)Study completedNCT01471470
What this trial is testing

Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Asan Medical Center 31
Testing effectiveness (Phase 2)UnknownNCT03322969
What this trial is testing

Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy

Who this might be right for
Locally Advanced Gastric Cancer
Peking Union Medical College Hospital 60
Testing effectiveness (Phase 2)WithdrawnNCT03623776
What this trial is testing

Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.

Who this might be right for
Efficacy and Safety
Sun Yat-sen University
Testing effectiveness (Phase 2)Ended earlyNCT02379585
What this trial is testing

Fasting on Newly Diagnosed Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Western Regional Medical Center 8
Not applicableLooking for participantsNCT05184582
What this trial is testing

Physical Exercise During Preoperative Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
Karolinska Institutet 712
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07616362
What this trial is testing

Personalize (Signature Driven) Neoadjuvant Chemotherapy Trial for Patients With Resectable Borderline Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Federation Francophone de Cancerologie Digestive 110
Testing effectiveness (Phase 2)Study completedNCT03666442
What this trial is testing

Early Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal Cancer

Who this might be right for
Rectal Cancer
West China Hospital 61
Testing effectiveness (Phase 2)UnknownNCT04060459
What this trial is testing

Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Third Military Medical University 50
Testing effectiveness (Phase 2)Study completedNCT02307227
What this trial is testing

Phase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- Tumors

Who this might be right for
Breast Neoplasms
Centro di Riferimento Oncologico - Aviano 46
Not applicableUnknownNCT01612247
What this trial is testing

Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
University of Vermont 13
Testing effectiveness (Phase 2)Study completedNCT04383743
What this trial is testing

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Who this might be right for
Stage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8Muscle Invasive Bladder Carcinoma
University of Washington 17
Testing effectiveness (Phase 2)Study completedNCT00525759
What this trial is testing

Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer

Who this might be right for
Breast Cancer
Sheffield Teaching Hospitals NHS Foundation Trust 40
Testing effectiveness (Phase 2)Study completedNCT00675259
What this trial is testing

Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer

Who this might be right for
Breast Cancer
Ohio State University Comprehensive Cancer Center 33
Not applicableStudy completedNCT02827370
What this trial is testing

CAREFOR: Precision Medicine Driving Precision Nutrition for the Treatment of NeoAdjuvant Breast Cancer

Who this might be right for
Breast Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06728618
What this trial is testing

Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Resectable Oral and Oropharyngeal Squamous Cell Carcinoma+1 more
Shanghai Zhongshan Hospital
Testing effectiveness (Phase 2)UnknownNCT04367025
What this trial is testing

Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 70
Not applicableLooking for participantsNCT07169708
What this trial is testing

A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)

Who this might be right for
Non Small Cell Lung Cancer NSCLC
Ono Pharmaceutical Co., Ltd. 100
Not applicableUnknownNCT06332976
What this trial is testing

PrefeRences And ChemoTherapy In Breast Cancer patiEnts

Who this might be right for
Female Breast Cancer
European Institute of Oncology 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT05710666
What this trial is testing

Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)

Who this might be right for
HER2-positive Breast Cancer
Cancer Trials Ireland 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT04666090
What this trial is testing

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Second Affiliated Hospital, School of Medicine, Zhejiang University 42
Load More Results
28